Iilun Murphy decided to step down as Office of Generic Drugs director for an associate director position, another senior ...

The MedTech Conference, hosted by AdvaMed, will bring more than 4,000 industry leaders to Boston Oct. 18–21 to discuss major ...

With the revised EU pharma directive making antimicrobials prescription-only by default, AESGP and national associations in ...

Cosmetics Europe and eight other European brand and manufacturer groups said online marketplaces, social media and ...

AI “dis-intermediates all of the things that we've tried to do to help patients make proper choices, not only with regular ...

The FDA is encouraging lupus drug sponsors to consider enrolling pediatric patients in or alongside their pivotal trials to ...

Thirteen companies received US FDA warning letters between April and September 2026, including BlephEx, Koven Technologies ...

The negative PFS result for the cancer vaccine drew disappointment, but the Phase II/III AHEAD-MERIT trial’s statistical plan ...

There are many treatments for inherited retinal dystrophies in development, including products from SparingVision, Atsena and Ocugen. Guidance is needed to address the distinct challenges involved ...

CMS Medicare Director David Brooks acknowledged concerns about the impact that Medicare negotiated prices for Part B drugs ...

International weakness and an Abiomed slump weigh on the segment, while executives promise a better fourth quarter.

Eli Lilly’s oral GLP-1 contender orforglipron is among four new drugs up for marketing approval recommendations by the ...